DIABETES IN NOD MICE DOES NOT REQUIRE LYMPHOCYTES-T EXPRESSING V-BETA-8 OR V-BETA-5

被引:19
作者
MCDUFFIE, M
机构
[1] UNIV COLORADO,HLTH SCI CTR,BARBARA DAVIS CTR CHILDHOOD DIABET,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,DENVER,CO 80262
关键词
D O I
10.2337/diabetes.40.11.1555
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The incidence of destructive pancreatic infiltrates and overt diabetes in animal models of insulin-dependent (type I) diabetes mellitus can be greatly reduced by inactivating or eliminating most T lymphocytes early in life. Because of theoretical and practical concerns about inducing long-term pan-T-lymphocyte inactivation for prevention or treatment of type I diabetes in humans, we hoped that more selective suppression of only the diabetogenic T lymphocyte population might be possible. To this end, two groups suggested that diabetogenic subpopulations of T lymphocytes in NOD mice could be identified by the protein sequence of their T-lymphocyte receptors. This assertion was based on experimental elimination of candidate T-lymphocyte subpopulations in two different short-term models of diabetes induction in NOD mice. For these experiments, identification and elimination of T-lymphocyte subsets were accomplished with monoclonal antibodies that bind specifically to the variable region of the beta-chain (V-beta) of the T-lymphocyte antigen receptor and divide the T-lymphocyte pool of the NOD mouse into approximately 20 V-beta-subsets. To test the relationship between the two T-lymphocyte V-beta-subsets implicated in these studies and pancreatic beta-cell destruction in unmanipulated animals, both T-lymphocyte subpopulations identified were genetically eliminated from NOD-derived mice by introduction of a mutant T-lymphocyte receptor V-beta-gene, from which these sequences are genomically deleted. Histological evidence of severe beta-cell destruction and overt diabetes was found in mice homozygous for the deleted V-beta-gene, indicating that neither V-beta-gene segment identified in previous studies is required for diabetogenesis in unmanipulated diabetes-prone mice.
引用
收藏
页码:1555 / 1559
页数:5
相关论文
共 17 条
[1]   LIMITED HETEROGENEITY OF T-CELL RECEPTORS FROM LYMPHOCYTES MEDIATING AUTOIMMUNE ENCEPHALOMYELITIS ALLOWS SPECIFIC IMMUNE INTERVENTION [J].
ACHAORBEA, H ;
MITCHELL, DJ ;
TIMMERMANN, L ;
WRAITH, DC ;
TAUSCH, GS ;
WALDOR, MK ;
ZAMVIL, SS ;
MCDEVITT, HO ;
STEINMAN, L .
CELL, 1988, 54 (02) :263-273
[2]   PREVENTION OF CYCLOPHOSPHAMIDE-INDUCED DIABETES BY ANTI-V-BETA-8 LYMPHOCYTE-T - RECEPTOR MONOCLONAL-ANTIBODY THERAPY IN NOD WEHI MICE [J].
BACELJ, A ;
CHARLTON, B ;
MANDEL, TE .
DIABETES, 1989, 38 (11) :1492-1495
[3]   MURINE T-CELL RECEPTOR MUTANTS WITH DELETIONS OF BETA-CHAIN VARIABLE REGION GENES [J].
BEHLKE, MA ;
CHOU, HS ;
HUPPI, K ;
LOH, DY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (03) :767-771
[4]   BOTH RAT AND MOUSE T-CELL RECEPTORS SPECIFIC FOR THE ENCEPHALITOGENIC DETERMINANT OF MYELIN BASIC-PROTEIN USE SIMILAR V-ALPHA AND V-BETA CHAIN GENES EVEN THOUGH THE MAJOR HISTOCOMPATIBILITY COMPLEX AND ENCEPHALITOGENIC DETERMINANTS BEING RECOGNIZED ARE DIFFERENT [J].
BURNS, FR ;
LI, XO ;
SHEN, N ;
OFFNER, H ;
CHOU, YK ;
VANDENBARK, AA ;
HEBERKATZ, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (01) :27-39
[5]   ISLET-SPECIFIC T-CELL CLONES FROM NONOBESE DIABETIC MICE EXPRESS HETEROGENEOUS T-CELL RECEPTORS [J].
CANDEIAS, S ;
KATZ, J ;
BENOIST, C ;
MATHIS, D ;
HASKINS, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (14) :6167-6170
[6]   GERMLINE ORGANIZATION OF THE MURINE T-CELL RECEPTOR BETA-CHAIN GENES [J].
CHOU, HS ;
NELSON, CA ;
GODAMBE, SA ;
CHAPLIN, DD ;
LOH, DY .
SCIENCE, 1987, 238 (4826) :545-548
[7]  
HARADA M, 1908, INSULITIS TYPE I DIA
[8]   CONSERVED ORGANIZATION OF THE HUMAN AND MURINE T-CELL RECEPTOR BETA-GENE FAMILIES [J].
LAI, E ;
CONCANNON, P ;
HOOD, L .
NATURE, 1988, 331 (6156) :543-546
[9]   ABSENCE OF INSULITIS AND OVERT DIABETES IN ATHYMIC NUDE-MICE WITH NOD GENETIC BACKGROUND [J].
MAKINO, S ;
HARADA, M ;
KISHIMOTO, Y ;
HAYASHI, Y .
EXPERIMENTAL ANIMALS, 1986, 35 (04) :495-498
[10]  
MCDUFFIE M, 1988, J IMMUNOL, V141, P1840